Chemed Corp
CHE
Positions held
Your positionsCHE isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Chemed Corp is well-positioned in the healthcare sector, benefiting from an aging population and increasing demand for medical care facilities.
- Revenue increased by 3% compared to the prior quarter, reaching $658 million.
- The company has shown strong earnings growth of 43.7% year-over-year.
- Despite growth, Chemed's operating margin has compressed to 12.9%, indicating potential challenges in cost management.
- Gross margin decreased to 32.8%, down from 35.2% in the previous quarter.
- The current ratio stands at 0.911, suggesting potential liquidity concerns.
Fundamentals
| Market cap | $6.51B | Enterprise value | $6.74B | Trailing P/E | 25.06 | Forward P/E | 18.11 |
| PEG | 1.83 | Price / book | 7.81 | Beta | 0.51 | Dividend yield | 0.56% |
| Revenue growth | 8.8% | Earnings growth | 43.7% | Gross margin | 33.1% | Operating margin | 13.3% |
| Profit margin | 10.6% | ROE | 27.1% | ROA | 13.5% | Debt / equity | 0.35 |
| Current ratio | 0.91 | Free cash flow | $307.86M | Analyst recommendation | buy | Mean target | $571.60 |
| 52w high | $557.00 | 52w low | $365.21 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | — | $658M | $639M | $625M | $619M | $647M |
| Op margin | — | 12.9% | 16.2% | 12.0% | 11.2% | 14.6% |
| Net income | — | $66.3M | $76.8M | $64.2M | $52.5M | $71.8M |
| Gross margin | — | 32.8% | 35.2% | 31.5% | 29.8% | 33.5% |
| Gross profit | — | $216M | $225M | $197M | $185M | $216M |
| Operating income | — | $84.6M | $104M | $74.8M | $69.0M | $94.8M |
- Revenue +3% vs prior quarter ($658M vs $639M).
- Gross margin 32.8% (was 35.2% prior quarter).
- Operating margin compressed to 12.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $2.5B | $2.4B | $2.3B | $2.1B |
| Op margin | 13.5% | 15.1% | 15.1% | 16.3% |
| Net income | $265M | $302M | $273M | $250M |
| Gross margin | 32.5% | 35.1% | 35.3% | 35.8% |
| Gross profit | $823M | $854M | $799M | $765M |
| Operating income | $341M | $367M | $343M | $347M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
2026-10-01 · 3 Small-Cap Stocks with Questionable Fundamentals
2026-09-30 · Chemed Insider Sold Shares Worth $1,026,900, According to a Recent SEC Filing
2026-09-26 · Chemed (CHE) Stock May Be 26% Undervalued On Franchise Territory Deal
2026-09-25 · UBS Initiates Chemed at Buy With $650 Price Target
2026-09-22 · Chemed (CHE) Buys a $60.6M Roto-Rooter Franchise. Can Ownership Lift Returns?
2026-09-21 · Chemed Insider Sold Shares Worth $1,002,800, According to a Recent SEC Filing
2026-09-16 · Chemed Unit Buys Franchise Territory in California
2026-09-16 · Roto-Rooter Buys Largest Franchisee Territory
2026-09-08 · Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
2026-09-06 · Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040
2026-08-27 · Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
Price (daily)
Full chart · RSI · MACD · patterns